4593.T
HEALIOS K.K.
グロース · 医薬品 · 医薬品 · JP
JPY 293.00
−0.68%Year over year
Reported trailing growth
- Revenue
- -81.4%
- EBITDA
- —
- EBIT
- -17.5%
- EPS
- +50.0%
- Free cash flow
- -81.9%
- Operating cash flow
- -74.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.9%
- EBITDA
- -20.4%
- EBIT
- -17.5%
- Net income
- +47.7%
- EPS
- +57.0%
- Free cash flow
- -81.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026